Water pills tested in dialysis patients – but study stops early
NCT ID NCT05915286
First seen May 09, 2026 · Last updated May 09, 2026
Summary
This small pilot study tested two types of water pills (furosemide and chlorthalidone) in people on dialysis who still make some urine. The goal was to see if these medications could help preserve the little kidney function they have left, increase urine output, and reduce weight gain between dialysis sessions. Only 2 people enrolled before the study was stopped, so no firm conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE ON DIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alberta
Edmonton, Alberta, T6G 2B7, Canada
Conditions
Explore the condition pages connected to this study.